Clinical Course and Risk Factors Affecting Mortality in Patients with Solid Organ Malignancies and COVID-19 Infection: A Retrospective Case-Control Study
Infectious Diseases and Clinical Microbiology · 30.03.2026
DOI: 10.36519/idcm.2026.861 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Infectious Diseases and Clinical Microbiology, online erschienen am 30.03.2026. Verfasst von Tazegül Gül und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Ankara University, Ankara, Türkiye. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
Patients with solid organ malignancy (SOM) constitute a high-risk group during the COVID-19 pandemic. Current evidence suggests that this population is more likely to experience severe clinical outcomes, higher hospitalization rates, and increased mortality following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to investigate the clinical course of COVID-19 in patients with SOM and to determine its impact on mortality. Materials and Methods: This retrospective case-control study included patients aged 18 years and older who tested positive for SARS-CoV-2 by polymerase chain reaction (PCR). As a control group, patients without malignancy but with similar characteristics in terms of age, sex, comorbidities, and vaccination status were selected. Comparisons between the two groups were performed, and risk factors associated with mortality were analyzed.
Results
A total of 580 patients with COVID-19 were included in the study, comprising 144 patients with SOM and 436 patients without SOM. Patients with SOM had significantly higher rates of hospital admission (p412.5 U/L (OR: 2.682) were found to significantly increase the risk of mortality. Notably, the presence of solid organ malignancy was associated with approximately a 3.8-fold higher risk of death.
Conclusion
Patients with SOM carry a significantly increased risk of mortality during COVID-19 infection. In this patient group, careful evaluation of age, sex, inflammatory parameters, and biomarker levels is warranted. These findings underscore the importance of early identification of high-risk groups and the implementation of personalized treatment strategies in the management of COVID-19. Keywords: COVID-19, solid organ malignancy, mortality, risk factors, retrospective case-control study
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Ankara University, Ankara, Türkiye.
ORCID-Profile: Tazegül Gül, Elif Mukime Sarıcaoğlu, Güle Çınar, Sevinç Ballı, İsmail Balık
Zitieren
APA
Gül, T., Sarıcaoğlu, E. M., Çınar, G., Ballı, S., & Balık, İ. (2026). Clinical Course and Risk Factors Affecting Mortality in Patients with Solid Organ Malignancies and COVID-19 Infection: A Retrospective Case-Control Study. Infectious Diseases and Clinical Microbiology. https://doi.org/10.36519/idcm.2026.861
Vancouver
Gül T, Sarıcaoğlu EM, Çınar G, Ballı S, Balık İ. Clinical Course and Risk Factors Affecting Mortality in Patients with Solid Organ Malignancies and COVID-19 Infection: A Retrospective Case-Control Study. Infectious Diseases and Clinical Microbiology. 2026. doi:10.36519/idcm.2026.861
BibTeX
@article{Gl2026,
author = {Gül, Tazegül and Sarıcaoğlu, Elif Mukime and Çınar, Güle and Ballı, Sevinç and Balık, İsmail},
title = {Clinical Course and Risk Factors Affecting Mortality in Patients with Solid Organ Malignancies and COVID-19 Infection: A Retrospective Case-Control Study},
journal = {Infectious Diseases and Clinical Microbiology},
year = {2026},
doi = {10.36519/idcm.2026.861}
}
EUVIMED